© John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Edited By: Thomas Bieber and Hans-Uwe Simon
Impact Factor: 6.028
ISI Journal Citation Reports © Ranking: 2014: 2/24 (Allergy); 17/148 (Immunology)
Online ISSN: 1398-9995
Associated Title(s): Pediatric Allergy and Immunology
Free Article Hereditary Angioedema (HAE)
C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks – final results of the I.M.P.A.C.T.2 study
Authors: T. J. Craig, A. K. Bewtra, S. L. Bahna, D. Hurewitz, L. C. Schneider, R. J. Levy, J. N. Moy, J. Offenberger, K. W. Jacobson, W. H. Yang, F. Eidelman, G. Janss, F. R. Packer13, M. A. Rojavin, T. Machnig, H.-O. Keinecke, R. L. Wasserman
Volume 66: Issue 12
This article has been made freely available through a grant from CSL Behring.
Click here to view the slide show.
The HAE Awareness Programme is an online CME (EACCME) accredited programme to help with the diagnosis and treatment of hereditary angioedema (HAE). Topics include pathophysiology and epidemiology, key symptoms of acute attacks, current methods of diagnosis, treatment options and management recommendations. Specifically designed for all healthcare professionals whose patients have, or might have, undiagnosed HAE, including: Acute care physicians, Gastroenterologists, Allergists, Immunologists, Dermatologists, and Paediatricians.
The CME website is accessible at www.hae-awareness.net